Catalyst Pharmaceuticals CPRX
CPRX
$31.49 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Catalyst Pharmaceuticals (CPRX) Return on Equity [ROE] (2011 - 2026)

Updated

Catalyst Pharmaceuticals (CPRX) posted Return on Equity [ROE] of 22.50% for Q1 2026, down 3.43 percentage points from 25.93% a year earlier and down 0.36 percentage points from the prior quarter.

Analysis

Catalyst Pharmaceuticals (CPRX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Catalyst Pharmaceuticals' Return on Equity [ROE] came in at 25.49%, down 3.90 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -32.81 percentage points (FY2020 to FY2025).
  • In prior years, Catalyst Pharmaceuticals' Return on Equity [ROE] was 29.38% in FY2024 (+8.63 pp), 20.75% in FY2023 (-12.01 pp), 32.76% in FY2022 (+11.78 pp) and 20.98% in FY2021 (-37.32 pp).
  • The Q1 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q3 2024.
  • On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of +1.54 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2025, with a gain of 13.64 percentage points; the weakest was Q3 2021, with a drop of 31.90 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 22.87% (Q4 2025), 24.50% (Q3 2025) and 25.29% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Catalyst Pharmaceuticals 3.85 Bn 1.04 Bn 134.92 Mn 22.50%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 22.50%
Dec 31, 2025 22.87%
Sep 30, 2025 24.50%
Jun 30, 2025 25.29%
Mar 31, 2025 25.93%
Dec 31, 2024 23.61%
Sep 30, 2024 22.49%
Jun 30, 2024 11.65%
Mar 31, 2024 13.72%
Dec 31, 2023 19.39%
Sep 30, 2023 17.14%
Jun 30, 2023 32.60%
Mar 31, 2023 31.35%
Dec 31, 2022 29.13%
Sep 30, 2022 26.18%
Jun 30, 2022 23.63%
Mar 31, 2022 21.10%
Dec 31, 2021 19.47%
Sep 30, 2021 21.47%
Jun 30, 2021 40.60%
API Access

Catalyst Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CPRX&period=max&api_key=YOUR_API_KEY